
CAS 1199350-02-1
:Itraconazole Desethylene-seco-piperazine Di-N-formyl Impurity
Description:
Itraconazole Desethylene-seco-piperazine Di-N-formyl Impurity, identified by its CAS number 1199350-02-1, is a chemical compound related to the antifungal agent itraconazole. This impurity is characterized by its structural modifications, which include the desethylene and seco-piperazine moieties, along with two formyl groups. Such modifications can influence the compound's solubility, stability, and biological activity compared to the parent itraconazole molecule. Typically, impurities like this can arise during the synthesis or degradation of pharmaceuticals and may affect the overall efficacy and safety profile of the drug. The presence of impurities is a critical consideration in pharmaceutical development, as they can impact the pharmacokinetics and pharmacodynamics of the active ingredient. Analytical techniques such as HPLC, NMR, and mass spectrometry are often employed to identify and quantify such impurities in drug formulations. Understanding the characteristics of this impurity is essential for ensuring the quality and safety of itraconazole-containing products.
Formula:C35H36Cl2N8O6
Synonyms:- Formamide, N-[2-[[4-[[(2R,4S)-2-(2,4-dichlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]formylamino]ethyl]-N-[4-[1,5-dihydro-1-(1-methylpropyl)-5-oxo-4H-1,2,4-triazol-4-yl]phenyl]-, rel-
- ItracozoleDesethylene-seco-piperazineDi-N-formylImpurity
- Itraconazole Desethylene-seco-piperazine Di-N-formyl Impurity
Sort by
The purity filter is not visible because current products do not have associated purity data for filtering.
Found 3 products.
Itraconazole Desethylene-seco-piperazine Di-N-formyl Impurity
CAS:Controlled Product<p>Applications Itraconazole Desethylene-seco-piperazine Di-N-formyl Impurity is a by-product in the synthesis of Itraconazole Desethylene-seco-piperazine Mono-N-formyl Impurity (I937520), which is an impurity of Itraconazole (I937500). Itraconazole is an orally active antimycotic structurally related to Ketoconazole. Antifungal. It is a COVID19-related research product.<br>References Espinel-Ingroff, A., et al.: Antimicrob. Agents Chemother., 26, 5 (1984), Heykants, J., et al.: Mycoses, 32, Suppl 1, 67 (1989), Sugar, A.M.,et al.: Curr. Clin. Top. Infect. Dis., 13, 74 (1993),<br></p>Formula:C35H36Cl2N8O6Color and Shape:NeatMolecular weight:735.62


